Search

everythinglearnresearchcommunity

for

Search:↓

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Type I interferons play a key role in the development of various skin diseases.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Consider benefits and risks of new alopecia treatments for safety.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.